Valeria Tomarchio - Concepedia

Author

Valeria Tomarchio

Università Campus Bio-Medico ORCID

Also Known As

Ombretta Annibali, Tomarchio V, Tomarchio, Valeria, V Tomarchio, V. Tomarchio, V., Tomarchio, Valeria Tomarchio

Publications

297

Citations

H-Index

Concepts

All Affiliations

Università Campus Bio-Medico Istituti di Ricovero e Cura a Carattere Scientifico Campus Bio Medico University Hospital University of Rome Tor Vergata Policlinico Tor Vergata

About

Valeria Tomarchio is an author at Università Campus Bio-Medico specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	69
2	Immunology	2	2	29
3	Cell Biology	1	1	13
4	Cellular Therapies	1	1	13
5	Geriatrics	1	1	40

Valeria Tomarchio

Publications

140

Citations

H-Index

Page 1

	Year	Citations
A retrospective study on 73 elderly patients (≥75years) with aggressive B-cell non Hodgkin lymphoma: Clinical significance of treatment intensity and comprehensive geriatric assessment Francesco Marchesi, Natalia Cenfra, Lidia Altomare, Journal of Geriatric Oncology Retrospective StudyLymphoid NeoplasiaTreatment IntensityGeriatric OncologyElderly Patients	2013	40
A novel scoring system for TIGIT expression in classic Hodgkin lymphoma Ombretta Annibali, Antonella Bianchi, Alba Grifoni, Scientific Reports	2021	23
Protective Isolation for Patients with Haematological Malignancies: A Pilot Study Investigating Patients' Distress and Use of Time. Ombretta Annibali, Claudio Pensieri, Valeria Tomarchio, PubMed	2017	16
Gonadal Function Recovery and Fertility in Women Treated with Chemo- and/or Radiotherapy for Hodgkin’s and Non-Hodgkin Lymphoma Guido Gini, Ombretta Annibali, Diana Lupasco, Chemotherapy	2019	16
The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network ‘Rete Ematologica del Lazio per i Linfomi’ (RELLI) Ombretta Annibali, Stefan Hohaus, Francesco Marchesi, Leukemia & lymphoma/Leukemia and lymphoma	2019	16
MiR‐22, a serum predictor of poor outcome and therapy response in diffuse large B‐cell lymphoma patients Federica Rinaldi, Francesco Marchesi, Francesca Palombi, British Journal of Haematology Poor OutcomeImmunologyPathologyImmunotherapyTumor Biology	2021	16
Impact of IFN lambda 3/4 single nucleotide polymorphisms on the cytomegalovirus reactivation in autologous stem cell transplant patients Ombretta Annibali, Livia Piccioni, Valeria Tomarchio, PLoS ONE Cell TherapyGeneticsImmunodeficienciesImmunologyTransplantation Medicine	2018	13

Page 1